Disbures equity capital.

No definition available.

Name:	opgn_DisburesEquityCapital
Namespace Prefix:	opgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Drew down amount.

+ References

No definition available.

+ Details

Name:	opgn_DrewDownAmount
Namespace Prefix:	opgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The EIB waived for curetis to have equity capital raised to disburse the third tranche.

+ References

No definition available.

+ Details

Name:	opgn_EIBWaivedForCuretisToHaveEquityCapitalRaisedToDisburseThirdTranche
Namespace Prefix:	opgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Maturity period.

+ References

No definition available.

+ Details

Name:	opgn_MaturityPeriod
Namespace Prefix:	opgn_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Participation percentage interest.

+ References

No definition available.

+ Details

Name:	opgn_ParticipationPercentageInterest
Namespace Prefix:	opgn_
Data Type:	dtr:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-30

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-31

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-32

+ Details

Name:	us-gaap_FairValueOptionQuantitativeDisclosuresLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

+ Details

Name:	us-gaap_GoodwillImpairedAccumulatedImpairmentLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-28

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482665/350-30-50-3

+ Details

Name:	us-gaap_ImpairmentOfIntangibleAssetsFinitelived
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_UnsecuredLongTermDebt
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=opgn_CuretisGmbHMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=opgn_EuropeanInvestmentBankMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=opgn_OpGensEquityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ConsolidatedEntitiesAxis=opgn_CuretisGmbHMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Fair Value Measurements (Details) € in Millions	1 Months Ended	9 Months Ended	12 Months Ended
Fair Value Measurements (Details) € in Millions	Jun. 30, 2019 EUR (€)	Sep. 30, 2023	Dec. 31, 2022 USD ($)	May 23, 2023	Jul. 09, 2020 EUR (€)	Dec. 31, 2016 EUR (€)
Fair Value Disclosures [Line Items]
Participation percentage interest					2.10%
Goodwill impairment expense \| $			$ 6,940,549
Impairment of intangible assets \| $			$ 5,407,699
Fair Value, Recurring [Member] \| Curetis GmbH [Member]
Fair Value Disclosures [Line Items]
Participation percentage interest	2.10%
European Investment Bank [Member] \| Curetis GmbH [Member] \| Share-Based Payment Arrangement, Tranche Three [Member]
Fair Value Disclosures [Line Items]
Disbures equity capital					€ 5.0
European Investment Bank [Member] \| OpGen's Equity [Member] \| Share-Based Payment Arrangement, Tranche Three [Member]
Fair Value Disclosures [Line Items]
Maturity period		the Company entered into a Waiver and Amendment Letter which increased the PPI to 0.75% upon maturity between mid-2024 and mid-2025.
European Investment Bank [Member] \| Fair Value, Recurring [Member] \| Curetis GmbH [Member]
Fair Value Disclosures [Line Items]
Unsecured loan financing facility						€ 25.0
European Investment Bank [Member] \| Fair Value, Recurring [Member] \| Curetis GmbH [Member] \| Share-Based Payment Arrangement, Tranche Three [Member]
Fair Value Disclosures [Line Items]
Disbures equity capital	€ 5.0
Participation percentage interest	2.10%
European Investment Bank [Member] \| Fair Value, Recurring [Member] \| Curetis GmbH [Member] \| Share-Based Payment Arrangement, Tranche Three [Member] \| Minimum [Member]
Fair Value Disclosures [Line Items]
EIB waived for curetis to have equity capital raised to disburse the third tranche	€ 15.0
European Investment Bank [Member] \| Fair Value, Recurring [Member] \| OpGen's Equity [Member] \| Share-Based Payment Arrangement, Tranche Three [Member]
Fair Value Disclosures [Line Items]
Participation percentage interest				0.75%	0.30%
European Investment Bank [Member] \| Fair Value, Recurring [Member] \| Curetis GmbH [Member] \| Share-Based Payment Arrangement, Tranche Three [Member]
Fair Value Disclosures [Line Items]
Disbures equity capital	€ 5.0